Literature DB >> 22815171

Revolutionizing medicine in the 21st century through systems approaches.

Leroy Hood1, Rudi Balling, Charles Auffray.   

Abstract

Personalized medicine is a term for a revolution in medicine that envisions the individual patient as the central focus of healthcare in the future. The term "personalized medicine", however, fails to reflect the enormous dimensionality of this new medicine that will be predictive, preventive, personalized, and participatory-a vision of medicine we have termed P4 medicine. This reflects a paradigm change in how medicine will be practiced that is revolutionary rather than evolutionary. P4 medicine arises from the confluence of a systems approach to medicine and from the digitalization of medicine that creates the large data sets necessary to deal with the complexities of disease. We predict that systems approaches will empower the transition from conventional reactive medical practice to a more proactive P4 medicine focused on wellness, and will reverse the escalating costs of drug development an will have enormous social and economic benefits. Our vision for P4 medicine in 10 years is that each patient will be associated with a virtual data cloud of billions of data points and that we will have the information technology for healthcare to reduce this enormous data dimensionality to simple hypotheses about health and/or disease for each individual. These data will be multi-scale across all levels of biological organization and extremely heterogeneous in type - this enormous amount of data represents a striking signal-to-noise (S/N) challenge. The key to dealing with this S/N challenge is to take a "holistic systems approach" to disease as we will discuss in this article.
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Year:  2012        PMID: 22815171      PMCID: PMC3962497          DOI: 10.1002/biot.201100306

Source DB:  PubMed          Journal:  Biotechnol J        ISSN: 1860-6768            Impact factor:   4.677


  20 in total

1.  A self-powered, one-step chip for rapid, quantitative and multiplexed detection of proteins from pinpricks of whole blood.

Authors:  Jun Wang; Habib Ahmad; Chao Ma; Qihui Shi; Ophir Vermesh; Udi Vermesh; James Heath
Journal:  Lab Chip       Date:  2010-10-06       Impact factor: 6.799

Review 2.  Diseases as network perturbations.

Authors:  Antonio del Sol; Rudi Balling; Lee Hood; David Galas
Journal:  Curr Opin Biotechnol       Date:  2010-08-13       Impact factor: 9.740

3.  Nontargeted elucidation of metabolic pathways using stable-isotope tracers and mass spectrometry.

Authors:  Karsten Hiller; Christian M Metallo; Joanne K Kelleher; Gregory Stephanopoulos
Journal:  Anal Chem       Date:  2010-08-01       Impact factor: 6.986

4.  External validation of exhaled breath profiling using an electronic nose in the discrimination of asthma with fixed airways obstruction and chronic obstructive pulmonary disease.

Authors:  N Fens; A C Roldaan; M P van der Schee; R J Boksem; A H Zwinderman; E H Bel; P J Sterk
Journal:  Clin Exp Allergy       Date:  2011-07-07       Impact factor: 5.018

Review 5.  Predictive, personalized, preventive, participatory (P4) cancer medicine.

Authors:  Leroy Hood; Stephen H Friend
Journal:  Nat Rev Clin Oncol       Date:  2011-03       Impact factor: 66.675

6.  Full dynamic range proteome analysis of S. cerevisiae by targeted proteomics.

Authors:  Paola Picotti; Bernd Bodenmiller; Lukas N Mueller; Bruno Domon; Ruedi Aebersold
Journal:  Cell       Date:  2009-08-06       Impact factor: 41.582

7.  Analysis of genetic inheritance in a family quartet by whole-genome sequencing.

Authors:  Jared C Roach; Gustavo Glusman; Arian F A Smit; Chad D Huff; Robert Hubley; Paul T Shannon; Lee Rowen; Krishna P Pant; Nathan Goodman; Michael Bamshad; Jay Shendure; Radoje Drmanac; Lynn B Jorde; Leroy Hood; David J Galas
Journal:  Science       Date:  2010-03-10       Impact factor: 47.728

8.  Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-kappaB.

Authors:  R C Langen; A M Schols; M C Kelders; E F Wouters; Y M Janssen-Heininger
Journal:  FASEB J       Date:  2001-05       Impact factor: 5.191

9.  Diagnosing lung cancer in exhaled breath using gold nanoparticles.

Authors:  Gang Peng; Ulrike Tisch; Orna Adams; Meggie Hakim; Nisrean Shehada; Yoav Y Broza; Salem Billan; Roxolyana Abdah-Bortnyak; Abraham Kuten; Hossam Haick
Journal:  Nat Nanotechnol       Date:  2009-08-30       Impact factor: 39.213

10.  A systems biology approach identifies molecular networks defining skeletal muscle abnormalities in chronic obstructive pulmonary disease.

Authors:  Nil Turan; Susana Kalko; Anna Stincone; Kim Clarke; Ayesha Sabah; Katherine Howlett; S John Curnow; Diego A Rodriguez; Marta Cascante; Laura O'Neill; Stuart Egginton; Josep Roca; Francesco Falciani
Journal:  PLoS Comput Biol       Date:  2011-09-01       Impact factor: 4.475

View more
  60 in total

1.  Medicalization and overdiagnosis: different but alike.

Authors:  Bjørn Hofmann
Journal:  Med Health Care Philos       Date:  2016-06

2.  Precision medicine and molecular imaging: new targeted approaches toward cancer therapeutic and diagnosis.

Authors:  Mojtaba Ghasemi; Iraj Nabipour; Abdolmajid Omrani; Zeinab Alipour; Majid Assadi
Journal:  Am J Nucl Med Mol Imaging       Date:  2016-11-30

Review 3.  From the exposome to mechanistic understanding of chemical-induced adverse effects.

Authors:  Beate I Escher; Jörg Hackermüller; Tobias Polte; Stefan Scholz; Achim Aigner; Rolf Altenburger; Alexander Böhme; Stephanie K Bopp; Werner Brack; Wibke Busch; Marc Chadeau-Hyam; Adrian Covaci; Adolf Eisenträger; James J Galligan; Natalia Garcia-Reyero; Thomas Hartung; Michaela Hein; Gunda Herberth; Annika Jahnke; Jos Kleinjans; Nils Klüver; Martin Krauss; Marja Lamoree; Irina Lehmann; Till Luckenbach; Gary W Miller; Andrea Müller; David H Phillips; Thorsten Reemtsma; Ulrike Rolle-Kampczyk; Gerrit Schüürmann; Benno Schwikowski; Yu-Mei Tan; Saskia Trump; Susanne Walter-Rohde; John F Wambaugh
Journal:  Environ Int       Date:  2016-12-08       Impact factor: 9.621

Review 4.  P4 medicine and osteoporosis: a systematic review.

Authors:  Klemen Kodrič; Klemen Čamernik; Darko Černe; Radko Komadina; Janja Marc
Journal:  Wien Klin Wochenschr       Date:  2016-11-21       Impact factor: 1.704

5.  Integrated Systems Biology Approach Identifies Novel Maternal and Placental Pathways of Preeclampsia.

Authors:  Nandor Gabor Than; Roberto Romero; Adi Laurentiu Tarca; Katalin Adrienna Kekesi; Yi Xu; Zhonghui Xu; Kata Juhasz; Gaurav Bhatti; Ron Joshua Leavitt; Zsolt Gelencser; Janos Palhalmi; Tzu Hung Chung; Balazs Andras Gyorffy; Laszlo Orosz; Amanda Demeter; Anett Szecsi; Eva Hunyadi-Gulyas; Zsuzsanna Darula; Attila Simor; Katalin Eder; Szilvia Szabo; Vanessa Topping; Haidy El-Azzamy; Christopher LaJeunesse; Andrea Balogh; Gabor Szalai; Susan Land; Olga Torok; Zhong Dong; Ilona Kovalszky; Andras Falus; Hamutal Meiri; Sorin Draghici; Sonia S Hassan; Tinnakorn Chaiworapongsa; Manuel Krispin; Martin Knöfler; Offer Erez; Graham J Burton; Chong Jai Kim; Gabor Juhasz; Zoltan Papp
Journal:  Front Immunol       Date:  2018-08-08       Impact factor: 7.561

6.  P4 medicine: how systems medicine will transform the healthcare sector and society.

Authors:  Mauricio Flores; Gustavo Glusman; Kristin Brogaard; Nathan D Price; Leroy Hood
Journal:  Per Med       Date:  2013       Impact factor: 2.512

Review 7.  Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management.

Authors:  Prescott G Woodruff; Alvar Agusti; Nicolas Roche; Dave Singh; Fernando J Martinez
Journal:  Lancet       Date:  2015-05-02       Impact factor: 79.321

Review 8.  Conceptual and Analytical Considerations toward the Use of Patient-Reported Outcomes in Personalized Medicine.

Authors:  Demissie Alemayehu; Joseph C Cappelleri
Journal:  Am Health Drug Benefits       Date:  2012-07

9.  2012 highlights in translational 'omics.

Authors:  Charles Auffray; Timothy Caulfield; Muin J Khoury; James R Lupski; Matthias Schwab; Timothy Veenstra
Journal:  Genome Med       Date:  2013-01-31       Impact factor: 11.117

Review 10.  Therapeutic potential of targeting the Eph/ephrin signaling complex.

Authors:  Nayanendu Saha; Dorothea Robev; Emilia O Mason; Juha P Himanen; Dimitar B Nikolov
Journal:  Int J Biochem Cell Biol       Date:  2018-10-19       Impact factor: 5.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.